Diabetes Pipeline
Diabetes Pipeline
LAS VEGAS, NV, UNITED STATES, January 20, 2025 /EINPresswire.com/ -- DelveInsight’s, “Diabetes Pipeline Insights” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the Diabetes Pipeline. Dive into DelveInsight's comprehensive report today! @ Diabetes Pipeline Outlook
Key takeaways from the Diabetes Pipeline Report
• In January 2025:- The purpose of this study is to assess the safety of insulin lispro-aabc in adult participants with Type 2 diabetes mellitus in India. The study will last about 33 weeks for each participant, including screening (1 week), Lead-in period (4 weeks), treatment period (26 weeks) and follow up period (2 weeks).
• DelveInsight’s Diabetes pipeline report depicts a robust space with 200+ active players working to develop 200+ pipeline therapies for Diabetes treatment.
• The leading Diabetes Companies such as Daewoong Tradipitant, Janssen Biotech,Zealand Pharma, Provention Bio, BioRestorative Therapies, Elevian, Kamada, Adocia, Oramed Pharmaceuticals, ImCyse, Histogen, Novo Nordisk, Enthera, ActoBio Therapeutics, Japan Tobacco, Avotres, and others.
• Promising Diabetes Therapies such as Aspirin, DA-2811, Forxiga, TG103, and others.
Stay ahead with the most recent pipeline outlook for Diabetes. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Diabetes Treatment Drugs
Diabetes Emerging Drugs Profile
• Enavogliflozin - Daewoong
Enavogliflozin (DWP 16001) is an orally available small molecule and sodium glucose transporter 2 inhibitor. The molecule is in phase-3 clinical trials for type-2 diabetic treatment. Enavogliflozin demonstrates the lowering of blood sugar and safety in diabetic patients in phase 2 clinical trials.
• Golimumab - Janssen Biotech
Golimumab is a human IgG1 monoclonal antibody, derived from immunizing genetically engineered mice with human TNFα. It inhibits soluble and transmembrane forms of TNF-α by binding to their specific receptors and blocking in consequence their bioactivity. It is currently under Phase II development for the treatment of Type 1 diabetes mellitus.
Explore groundbreaking therapies and clinical trials in the Diabetes Pipeline. Access DelveInsight's detailed report now! @ New Diabetes Drugs
Diabetes Companies
Daewoong Tradipitant, Janssen Biotech,Zealand Pharma, Provention Bio, BioRestorative Therapies, Elevian, Kamada, Adocia, Oramed Pharmaceuticals, ImCyse, Histogen, Novo Nordisk, Enthera, ActoBio Therapeutics, Japan Tobacco, Avotres, and others.
Diabetes pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
• Oral
• Parenteral
• intravitreal
• Subretinal
• Topical.
• Molecule Type
Diabetes Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Unveil the future of Diabetes Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Diabetes Market Drivers and Barriers- https://www.delveinsight.com/sample-request/diabetes-pipeline-insight?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Diabetes Pipeline Report
• Coverage- Global
• Diabetes Companies- Daewoong Tradipitant, Janssen Biotech,Zealand Pharma, Provention Bio, BioRestorative Therapies, Elevian, Kamada, Adocia, Oramed Pharmaceuticals, ImCyse, Histogen, Novo Nordisk, Enthera, ActoBio Therapeutics, Japan Tobacco, Avotres, and others.
• Diabetes Therapies- Aspirin, DA-2811, Forxiga, TG103, and others.
• Diabetes Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Diabetes Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Get the latest on Diabetes Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Diabetes Companies, Key Products and Unmet Needs- https://www.delveinsight.com/sample-request/diabetes-pipeline-insight?utm_source=einpresswire&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Diabetes: Overview
4. Causes
5. Mechanism of Action
6. Signs and Symptoms
7. Diagnosis
8. Disease Management
9. Pipeline Therapeutics
10. Comparative Analysis
11. Therapeutic Assessment
12. Assessment by Product Type
13. Assessment by Stage and Product Type
14. Assessment by Route of Administration
15. Assessment by Stage and Route of Administration
16. Assessment by Molecule Type
17. Assessment by Stage and Molecule Type
18. Diabetes – DelveInsight’s Analytical Perspective
19. In-depth Commercial Assessment
20. Diabetes companies’ collaborations, Licensing, Acquisition -Deal Value Trends
21. Diabetes Collaboration Deals
22. Company-Company Collaborations (Licensing / Partnering) Analysis
23. Company-University Collaborations (Licensing / Partnering) Analysis
24. Late Stage Products (Phase III)
25. Comparative Analysis
26. Enavogliflozin: Daewoong
27. Product Description
28. Research and Development
29. Product Development Activities
30. Mid Stage Products (Phase II)
31. Comparative Analysis
32. Golimumab: Janssen Biotech
33. Product Description
34. Research and Development
35. Product Development Activities
36. Drug profiles in the detailed report…..
37. Early Stage Products (Phase II/I)
38. Comparative Analysis
39. IMCY-0098: ImCyse
40. Product Description
41. Research and Development
42. Product Development Activities
43. Drug profiles in the detailed report…..
44. Pre-clinical and Discovery Stage Products
45. Comparative Analysis
46. ENT-001: Enthera
47. Product Description
48. Research and Development
49. Product Development Activities
50. Drug profiles in the detailed report…..
51. Inactive Products
52. Comparative Analysis
53. Diabetes Key Companies
54. Diabetes Key Products
55. Diabetes- Unmet Needs
56. Diabetes- Market Drivers and Barriers
57. Diabetes- Future Perspectives and Conclusion
58. Diabetes Analyst Views
59. Diabetes Key Companies
60. Appendix
List of Top Selling Market Research Reports in 2025
Varicose Vein Treatment Devices Market - https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Vascular Access Devices Market - https://www.delveinsight.com/report-store/vascular-access-device-market
Indwelling Catheters Market - https://www.delveinsight.com/report-store/indwelling-catheters-market
Healthcare Competitive Benchmarking - https://www.delveinsight.com/consulting/competitive-benchmarking-services
Lymphoedema Market - https://www.delveinsight.com/report-store/lymphoedema-market
Pacemakers Market - https://www.delveinsight.com/report-store/pacemakers-market
Myeloproliferative Neoplasms Market - https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
Surgical Mask & Respirator Market - https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Nk Cell Therapy Market - https://www.delveinsight.com/report-store/nk-cell-therapy-market
Novel Drug Delivery Devices Market - https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Testicular Neoplasm Market - https://www.delveinsight.com/report-store/testicular-cancer-pipeline-insight
Phototherapies For Psoriasis Market - https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Skin Neoplasm Market - https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market
Microscopy Device Market - https://www.delveinsight.com/report-store/microscopy-device-market
Bone Growth Stimulator Market - https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Urea Cycle Disorders Market - https://www.delveinsight.com/report-store/urea-cycle-disorders-market
Antibody Drug Conjugate Market - https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
Penile Cancer Market - https://www.delveinsight.com/report-store/penile-implants-market
Total Knee Arthroplasty Market - https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Cardiac Implantable Electronic Devices Market - https://www.delveinsight.com/report-store/cardiac-implantable-electronic-devices-cieds-market
Dyspepsia Market - https://www.delveinsight.com/report-store/functional-dyspepsia-epidemiology-forecast-insight
Lactose Intolerance Market - https://www.delveinsight.com/report-store/lactose-intolerance-market
Medical Marijuana Market - https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Asperger Syndrome Market - https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
Catheter Stabilization Devices Market - https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Yash Bhardwaj
DelveInsight
+91 9650213330
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
